Results 311 to 320 of about 222,467 (377)
Some of the next articles are maybe not open access.
American Journal of Therapeutics, 2020
Background: Advances in pump technology have increased the popularity of this treatment modality among patients with type 1 diabetes and recently also among patients with type 2 diabetes. Areas of Uncertainty: Four decades after the incorporation of the insulin pump in clinical use,
Revital, Nimri +2 more
semanticscholar +4 more sources
Background: Advances in pump technology have increased the popularity of this treatment modality among patients with type 1 diabetes and recently also among patients with type 2 diabetes. Areas of Uncertainty: Four decades after the incorporation of the insulin pump in clinical use,
Revital, Nimri +2 more
semanticscholar +4 more sources
The Diabetes Textbook, 2019
Insulin pump therapy has been around since the late 1970s. From the “Big Blue Brick” to the sensor-augmented pumps, significant improvements have been made in the technology. The first hybrid close loop device was approved for clinical use by the FDA in the fall of 2016.
Raquel N. Faradji +1 more
semanticscholar +3 more sources
Insulin pump therapy has been around since the late 1970s. From the “Big Blue Brick” to the sensor-augmented pumps, significant improvements have been made in the technology. The first hybrid close loop device was approved for clinical use by the FDA in the fall of 2016.
Raquel N. Faradji +1 more
semanticscholar +3 more sources
The Lancet Child & Adolescent Health, 2020
BACKGROUND Although continuous subcutaneous insulin infusion therapy (ie, insulin pump therapy) is associated with improved metabolic control compared with multiple daily insulin injections in children with type 1 diabetes, it is unclear when it is best ...
C. Kamrath +9 more
semanticscholar +1 more source
BACKGROUND Although continuous subcutaneous insulin infusion therapy (ie, insulin pump therapy) is associated with improved metabolic control compared with multiple daily insulin injections in children with type 1 diabetes, it is unclear when it is best ...
C. Kamrath +9 more
semanticscholar +1 more source
Understanding Insulin Pump Therapy
Journal of Community Health Nursing, 2015It is estimated that 375,000 Americans are utilizing insulin pump therapy to manage their diabetes. This article will educate community health care nurses regarding use of the insulin pump, and how to operate special settings for more effective glycemic control. Complications of pump therapy, as well as hyperglycemia, are not always avoidable; however,
George, Dajkovich, Thomas W, Barkley
openaire +2 more sources
Diabetes Technology & Therapeutics, 2020
Objectives: The objective of this population-based study was to identify factors associated with insulin pump therapy initiation in adults with insulin-requiring diabetes in France in 2015.
Lise Meunier +6 more
semanticscholar +1 more source
Objectives: The objective of this population-based study was to identify factors associated with insulin pump therapy initiation in adults with insulin-requiring diabetes in France in 2015.
Lise Meunier +6 more
semanticscholar +1 more source
Diabetes & Metabolism, 2019
AIMS To compare the efficacy of three timings to decrease basal insulin infusion rate to reduce exercise-induced hypoglycaemia in patients with type 1 diabetes (T1D) using pump therapy.
Amélie Roy-Fleming +9 more
semanticscholar +1 more source
AIMS To compare the efficacy of three timings to decrease basal insulin infusion rate to reduce exercise-induced hypoglycaemia in patients with type 1 diabetes (T1D) using pump therapy.
Amélie Roy-Fleming +9 more
semanticscholar +1 more source
Canadian Journal of Diabetes, 2020
BACKGROUND The Nova Scotia Insulin Pump Program (NSIPP) subsidizes the cost of insulin pump therapy for young patients (≤25 years) with type 1 diabetes. The first NSIPP evaluation focused on clinical outcomes rather than quality of life.
Emily Haynes +4 more
semanticscholar +1 more source
BACKGROUND The Nova Scotia Insulin Pump Program (NSIPP) subsidizes the cost of insulin pump therapy for young patients (≤25 years) with type 1 diabetes. The first NSIPP evaluation focused on clinical outcomes rather than quality of life.
Emily Haynes +4 more
semanticscholar +1 more source
Drug and Therapeutics Bulletin, 2012
Insulin pump therapy makes use of an external device to deliver insulin continuously from a refillable storage reservoir by means of a cannula placed under the skin. A pump is intended to simulate pancreatic function in that it can be programmed to deliver an adjustable basal rate of insulin throughout the day, with higher infusion ...
openaire +2 more sources
Insulin pump therapy makes use of an external device to deliver insulin continuously from a refillable storage reservoir by means of a cannula placed under the skin. A pump is intended to simulate pancreatic function in that it can be programmed to deliver an adjustable basal rate of insulin throughout the day, with higher infusion ...
openaire +2 more sources
Insulin Pump Therapy Reconsidered
JAMA: The Journal of the American Medical Association, 1986It has been recognized for some time that the traditional methods of treating type I diabetes mellitus (insulin-dependent diabetes mellitus) with a program of one or two daily insulin injections and diet and exercise planning are quite imperfect. With the advent of home blood glucose—monitoring techniques and glycosylated hemoglobin determinations, it ...
openaire +2 more sources